26 March 2019

The winner of the fifth edition of scientific pitch competition Radboud Talks is neuroscientist Suhas Vijayakumar, a PhD candidate at the Faculty of Social Sciences and the Donders Institute. Suhas’ pitch about what makes us human was chosen as the best by the expert jury. Research physician Sarah Verhoeff from the department of Medical Oncology won the audience award.

Suhas Vijayakumar was awarded with the jury prize of 1.000 euros science communication budget in a full LUX. In his research, he studies differences between brains of humans and our nearest evolutionary cousins, the great apes. By using brain scans to compare structural and functional differences, and studying behavioral aspects of various species, he hopes to contribute to the all-important question: ‘What makes us human?’. The expert jury – which consisted of science journalists Esther Thole and Jop de Vrieze, and Radboud Reflects programmer Anouta de Groot judged his pitch the most convincing in respect to content, clarity and charisma. In total, eight young scientists delivered three-minute pitches during the final.
The audience award went to Sarah Verhoeff, research physician at the Radboud Institute for Health Sciences (RIHS), theme Rare cancers. Her talk about how radioactivity can be used to ‘light up’ cancer cells made her win the hearts of the audience. She explained how a new therapy for cancer, immunotherapy, does not work for all patients. By using a radioactive label, Sarah is able to visualize all cancer cells in the body, and in this way she can evaluate the effectivity of the treatment.
Three minutes, no boring PowerPoints
Radboud Talks is a pitch competition where scientists from all disciplines tell their story in just three minutes for a live audience and jury. Traditional PowerPoint presentations are strictly prohibited, so no borings lists or charts. Instead, young researchers deliver science like you’ve never seen it before.
Besides pitches, there was music by the Student Big Band Nijmegen and a literary closing by writer Lisa Weeda from production company De Nieuwe Oost.

Related news items

Cognitive behavioral therapy reduces severe fatigue in patients with advanced cancer during treatment

28 January 2020

In Annals of Oncology, RIHS researchers Hanneke Poort, Marlies Peters, Winette van der Graaf, Ria Nijhuis-van der Sanden and colleagues showed significant effects of cognitive behavioral therapy on fatigue in patients with advanced cancer during treatment with palliative intent.

read more

Awarded KWF grants for Radboudumc researchers

18 December 2019

KWF is investing 2.7 million euros in five different studies at Radboudumc. The awards are part of the new round of funding by DCS, in which over 34 million euros will be granted to Dutch cancer research. We congratulate our researchers with this funding and wish them success with their great work.

read more

Exploration meeting Academic Alliance on Oncology

2 December 2019

Within the Academic Alliance, the Maastricht UMC+ and Radboudumc are already working together in several areas. And this is happening in more and more fields. On 27 November researchers from both umc's met during the fourth Exploration meeting, this time with the theme: Oncology.

read more

KWF Roadshow 11 November 2019

10 October 2019

In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field.

read more

Drug-induced interstitial lung disease in advanced breast cancer patients receiving everolimus

22 August 2019

In Targeted Oncology, Annelieke Willemsen, Carla van Herpen and colleagues, showed that pulmonary function test with diffusion capacity of the lungs for carbon monoxide and serum biomarkers can be of aid to differentiate everolimus-related interstitial lung disease from other respiratory problems.

read more

Internal KWF review procedure 2020

13 June 2019

In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

read more